Just as the sun sets, hundreds of groupers gather at their favorite hangouts along the shelf breaks in the southeast U.S., Gulf of Mexico and the Caribbean Basin to spawn – and they’re pretty vocal about it.
There are currently no medications available to specifically treat Lewy Body dementia (LBD). FAU's College of Medicine is spearheading the South Florida site for the first U.S. clinical trial for LBD.
A leading scientist has received $540,250 from the NIH to continue his groundbreaking research to develop new therapeutic agents for collagen-based diseases including multiple sclerosis, cancer and sepsis.
Inspired by pregnancy tests, scientists have developed a method to store microfluidic devices for months without refrigeration, giving developing countries an inexpensive and reliable way to treat patients.
The sub-tropics and the Arctic are rarely discussed together, and comparing shared experiences is expected to unlock new insights and generate a blueprint for solutions and adaptation.
A professor has identified 55 drug targets for the Zika virus from the human genome, leading to the identification of 79 FDA-approved drugs currently being used to treat other conditions such as cancer.
Research funded by a grant from the Bonefish & Tarpon Trust will design and test experimental means of growning bonefish for stock enhancement.
A psychology professor will continue a unique longitudinal study of bilingual development in children, focusing on language, literacy, cognitive growth, and academic achievement for Spanish-speaking children.
Where to live can be a dilemma for many Americans. A new FAU study is the first to evaluate the affordability of the U.S. Department of Housing and Urban Development (HUD) Section 8 Multifamily recipients.
Fruit flies can tell us a lot about sleep deprivation and metabolic disorders. A study is the first to show that a conserved gene - translin - works as a modulator of sleep in response to metabolic changes.